insulin resistance glp-1 Frontiers Mechanism by which excessive circulating
Description
Changes in A1C at 26 weeks were 1.51%, 1.30%, 0.99% and 0.46% for the dulaglutide 1.5 mg, dulaglutide 0.75 mg, exenatide and placebo groups, respectively (both doses of dulaglutide were superior to exenatide
The ISME Journal , 8 , 22182230
Garvey WT, Frias JP, Jastreboff AM, et al
Moreover, serum and ileal GLP-1 levels increased, but this improvement has not been observed in leptin receptor-deficient db/db mice (54)
In a 12-week study of 91 patients with chronic renal insufficiency, 37 patients with moderate renal insufficiency were randomized to JANUVIA 50 mg daily, while 14 patients with the same magnitude of renal impairment were randomized to placebo
[DOI] [PMC free article] [PubMed] [Google Scholar] 26.Mathiesen DS, Bagger JI, Bergmann NC, Lund A, Christensen MB, Vilsboll T, et al
